Hippocratic AI reviews

Leadership & Culture -From my perspective, leadership focused more on hype, investor optics, and valuation over building a sustainable, ethical solution. -I personally experienced pressure to present the company’s performance in ways that felt designed for optics rather than accuracy. -Decisions seemed driven by speed and revenue growth, often at the expense of what I perceived as patient safety. -When concerns were raised, pushback from c-suite leadership could be met with dismissive or hostile responses, public ridicule and verbal harassment which created a climate of fear and a "yes man" mentality Product Integrity -In my experience, public and client-facing representations of product capabilities and safety did not align with what I observed internally. This included staged demos, selectively edited materials, and performance metrics that didn’t match real-world results. -Sales was encouraged to pursue deals for features and outcomes that, at the time, I believed the product could not deliver, leading to client disappointment and erosion of trust. Compensation & Workload -I did not receive commission payouts following completion of sales targets based on verbal agreements and was presented with equity valuations that I later came to believe were unrealistic. -The work culture often required long hours, extensive travel, and sacrificing personal events, holidays, and weekends to meet expectations. Staffing & Structure -In my opinion, key leadership and clinical positions were sometimes filled with individuals who had limited relevant experience, which made it harder to challenge questionable decisions. -Teams operated in silos, which limited transparency and made it difficult to understand the full scope of product limitations or company decision-making.